Your browser version may not work well with NCBI's Web applications. More information
here...
-
Efficacy of olanzapine: an overview of pivotal clinical trials.
Psychopharmacology Division, Eli Lilly and Company, Indianapolis, IN 46285, USA.
Olanzapine is a new "atypical" antipsychotic agent that belongs chemically to the thienobenzodiazepine class. Its relatively greater binding affinity for 5-HT2 compared to D2 receptors makes it similar to the atypical agent clozapine, a serotonin/dopamine antagonist. Four double-blind pivotal studies, which compare olanzapine to placebo and/or haloperidol, are presented. The results suggest that olanzapine is as effective as haloperidol for positive symptoms and more effective than haloperidol for the treatment of the negative symptoms of schizophrenia.
PMID: 9265910 [PubMed - indexed for MEDLINE]
-
Related Articles
-
Patient Drug Information
-
Clozapine (Clozaril®, FazaClo®)
Clozapine is used to treat the symptoms of schizophrenia (a mental illness that causes disturbed or unusual thinking, loss of interest in life, and strong or inappropriate emotions) in patients who have not been helped b...
-